Covid-19: Cocktail antibodies injection used first time in Andhra Pradesh

This is the first time the cocktail antibodies injection has been used in Andhra Pradesh. (Representational picture/AFP)Premium
This is the first time the cocktail antibodies injection has been used in Andhra Pradesh. (Representational picture/AFP)
1 min read . Updated: 30 May 2021, 06:00 AM IST Staff Writer( with inputs from ANI )

Covid treatment: Samishta Hospital and Research Institute (SHRI) in Guntur has administered cocktail antibodies injection 'Regeneron' to two patients, news agency ANI reported on Sunday. This is the first time the cocktail antibodies injection has been used in Andhra Pradesh.

MORE FROM THIS SECTIONSee All

According to the report, Dr Kalyana Chakravarti and the team administered the injection. Chakravarti said that both the patients were showing good improvement.

He also said the patients were recovering well and will soon be discharged.

Chakravarti also informed that they have stopped using high dose steroids while using 'Regeneron'. They have, the doctor said, used stem cell therapy on 12 Covid patients.

He said using stem cell therapy is also giving good results. While two patients are ready for discharge, the doctor said, five more patients in ICU are recovering well.

The doctor thanked the patients for helping in clinical research, agency reported.

In India, an 84-year-old man from Haryana became the first person to be administered the Covid drug cocktail. This treatment came into limelight after it was administered to former US President Donald Trump when he tested positive for Covid last year.

Mohabbat Singh, who was under treatment at Gurugram's Medanta Hospital was given the drug over a 30 minute intravenous supply.

As per the news agency, the cocktail of two fast acting antibodies - Casirivimab and Imdevimab - is seen as a cutting-edge treatment that provides protection to Covid-19 patients with mild and moderate symptoms.





Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Never miss a story! Stay connected and informed with Mint. Download our App Now!!

Close